Martel-Pelletier, Johanne
Maheu, Emmanuel
Pelletier, Jean-Pierre
Alekseeva, Ludmila
Mkinsi, Ouafa
Branco, Jaime
Monod, Pierre
Planta, Frédéric
Reginster, Jean-Yves
Rannou, François
Article History
Received: 7 June 2018
Accepted: 16 November 2018
First Online: 11 December 2018
Compliance with Ethical Standards
:
: Jean-Yves Reginster received consulting fees or paid advisory boards for IBSA-Genevrier, Mylan, Radius Health, Pierre Fabre, lecture fees when speaking at the invitation of sponsor for IBSA-Genevrier, Mylan, CNIEL, Dairy Research Council (DRC), and Grant Support from Industry IBSA-Genevrier, Mylan, CNIEL, Radius Health. Jean-Pierre Pelletier is shareholder of ArthroLab Inc, and received consultant fees from Bioiberica, Pierre Fabre, TRB Chemedica, Zoetis. Johanne Martel-Pelletier is shareholder of ArthroLab Inc, and received consultant fees from Bioiberica, Pierre Fabre, TRB Chemedica, Zoetis. Emmanuel Maheu received fees or congress invitations in the past 3 years from Bioiberica, Celgene, Expanscience, IBSA, LCA Pharmaceutical, Meda-Mylan, Pfizer, Pierre Fabre, Rottapharm Biotech, TRB Chemedica. François Rannou received fees or congress invitations in the past three years from Expanscience, Fidia, Pierre Fabre, Thuasne, Genevrier, Sanofi, Servier, NASA. Ouafa Mkinsi received fees for lectures from AbbVie, Novartis, Pfizer, Pierre Fabre, Roche. Ludmila Alekseeva declared paid advisory boards for Pierre Fabre. Pierre Monod declared consulting fees for Pierre Fabre Health Care. Frédéric Planta is employed by Pierre Fabre. Jaime Branco declared paid advisory boards for Pierre Fabre.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, formal consent is not required.